T-vec has just won EU approval!! US FDA approval looks ominous. See
http://in.reuters.com/article/2015/10/23/us-amgen-cancer-europe-idINKCN0SH17520151023
"A first-in-class drug from Amgen based on a tumour-killing virus was given a green light by European regulators on Friday, paving the way for its approval within a couple of months.
Viral immunotherapy represents a completely new way of treating cancer, so it’s extremely exciting to see T-Vec become the first treatment of this type to gain the green light from European regulators," said Paul Workman, Chief Executive of The Institute of Cancer Research, London."
T-vec has just won EU approval!! US FDA approval looks ominous....
Add to My Watchlist
What is My Watchlist?